Bopindolol

This classification denotes an adrenergic beta-antagonist with the molecular formula C23H28N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KT304VZO57, chemically known as 2-propanol, 1-((1,1-dimethylethyl)amino)-3-((2-methyl-1h-indol-4-yl)oxy)-, benzoate (ester), (+-)- but generally known as bopindolol, which bears US NIH Compound Identifier 44112. Bopindolol most often comes in base and malonate forms. European Medicines Agency schedules Bopindolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05873MIG. World Health Organization schedules bopindolol in its Anatomical Therapeutic Chemical (ATC) Classification. BOPINDOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bopindolol under HS 29339990 and SITC 51577. As of Q4 2014, BOPINDOLOL remains the US FDA Preferred Term for this commodity. SMILES: O(C(CNC(C)(C)C)COC1C2C([NH]C(C2)C)CCC1)C(=O)C1CCCCC1.